{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T18:56:36Z","timestamp":1774119396785,"version":"3.50.1"},"reference-count":0,"publisher":"Frontline Medical Communications, Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.12788\/cutis.0467","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T15:47:52Z","timestamp":1651765672000},"source":"Crossref","is-referenced-by-count":2,"title":["Interstitial Granulomatous Dermatitis as an Adverse Reaction to Vedolizumab"],"prefix":"10.12788","volume":"109","author":[{"family":"Beuerlein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","container-title":["Cutis"],"original-title":[],"link":[{"URL":"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/CT109003167.PDF","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T15:47:53Z","timestamp":1651765673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdedge.com\/dermatology\/article\/252371\/autoimmune-diseases\/interstitial-granulomatous-dermatitis-adverse"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"URL":"https:\/\/doi.org\/10.12788\/cutis.0467","relation":{},"subject":[],"published":{"date-parts":[[2022,3]]}}}